DOI: 10.36347/sjams.2020.v08i01.016

Pages: 77-83

In this prospective randomized control study, we compared the clinical efficacy and safety of equal doses (15 mg) of 0.5% Hyperbaric Ropivacaine with 0.5 % Hyperbaric Bupivacaine for lower torso surgeries under Spinal Anaeasthesia. After Ethical Committee clearance and obtaining informed written consent from the patient, 80 patients of ASA 1 and 2 of age group 25-50 years posted for lower torso surgeries in Government. Mohan Kumaramangalam Medical College were included. Study population was divided into 2 groups- GROUP B(Patients in this group received intrathecal 15 mg (3 ml) of 0.5% Hyperbaric Bupivacaine) GROUP R(Patients in this group received intrathecal 15 mg (3 ml) of 0.5% Hyperbaric Ropivacaine which is prepared aseptically immediately before injection by adding 1 ml (250 mg) of autoclaved 25% dextrose ampoule (10 ml) to 2 ml of commercially available sterile preservative free isobaric solution of 0.75% Ropivacaine).From our study we conclude that the duration of sensory block and motor block in patients receiving 0.5 % hyperbaric Ropivacaine was less when compared to the patients receiving 0.5 % hyperbaric bupivacaine